<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JIA</journal-id>
<journal-id journal-id-type="hwp">spjia</journal-id>
<journal-id journal-id-type="nlm-ta">J Int Assoc Provid AIDS Care</journal-id>
<journal-title>Journal of the International Association of Providers of AIDS Care (JIAPAC)</journal-title>
<issn pub-type="ppub">2325-9574</issn>
<issn pub-type="epub">2325-9582</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1545109712460098</article-id>
<article-id pub-id-type="publisher-id">10.1177_1545109712460098</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>HIV Clinical Management</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Use of the Exercise Treadmill Test for the Assessment of Cardiac Risk Markers in Adults Infected with HIV</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lorenzo</surname>
<given-names>Andrea De</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1545109712460098">1</xref>
<xref ref-type="corresp" rid="corresp1-1545109712460098"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meirelles</surname>
<given-names>Vanderson</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1545109712460098">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vilela</surname>
<given-names>Felippe</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1545109712460098">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Souza</surname>
<given-names>Fernando Cesar C.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1545109712460098">1</xref>
</contrib>
<aff id="aff1-1545109712460098"><label>1</label>National Institute of Cardiology, Rio de Janeiro, Brazil</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1545109712460098">Andrea De Lorenzo, National Institute of Cardiology, Rua das Laranjeiras, 374 Rio de Janeiro, RJ, Brazil. Email: <email>andlorenzo@hotmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>12</volume>
<issue>2</issue>
<fpage>110</fpage>
<lpage>116</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec>
<title>Background:</title>
<p>Despite the association between HIV and coronary artery disease (CAD), there are no specific recommendations for the cardiovascular evaluation of the HIV-infected population. Besides being a tool for the evaluation of CAD, the exercise treadmill test (ETT) provides insights into functional capacity and autonomic function, which have been frequently affected in HIV infection, and thus may be useful in this setting.</p></sec>
<sec>
<title>Methods:</title>
<p>Forty-nine HIV-infected individuals without known CAD underwent ETT. Peak oxygen consumption during exercise (VO2 peak), functional capacity (in metabolic equivalents [METs]), exercise-induced ischemia, chronotropic incompetence (CI) and abnormal heart rate recovery (HRR) after exercise were studied.</p></sec>
<sec>
<title>Results:</title>
<p>VO2 peak was 31.4±4.8 mL/kg/min and functional capacity was 9.2±1.6 MET. CI was observed in 30.6%, and 10.2% had abnormal HRR. VO2 peak was lower in women and inversely correlated with age and body mass index. None of the patients displayed ischemic changes.</p></sec>
<sec>
<title>Conclusion:</title>
<p>Although functional capacity was good, risk markers such as CI and abnormal HRR were not infrequent. This study identifies a subgroup of HIV-infected patients–the older, overweight, or obese–who may have higher risk and deserve cardiovascular screening with the ETT.</p></sec>
</abstract>
<kwd-group>
<kwd>HIV</kwd>
<kwd>coronary artery disease</kwd>
<kwd>prevention</kwd>
<kwd>exercise treadmill test</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March/April 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1545109712460098">
<title>Introduction</title>
<p>HIV infection is a worldwide epidemic with huge economic and social implications.<sup>
<xref ref-type="bibr" rid="bibr1-1545109712460098">1</xref>
</sup> Since the advent of antiretroviral therapy (ART), survival has increased considerably. Also, muscle wasting and severe loss of functional capacity were very frequent before ART was available but are presently less common.<sup>
<xref ref-type="bibr" rid="bibr2-1545109712460098">2</xref>
<xref ref-type="bibr" rid="bibr3-1545109712460098"/>
<xref ref-type="bibr" rid="bibr4-1545109712460098"/>
<xref ref-type="bibr" rid="bibr5-1545109712460098"/>
<xref ref-type="bibr" rid="bibr6-1545109712460098"/>
<xref ref-type="bibr" rid="bibr7-1545109712460098"/>–<xref ref-type="bibr" rid="bibr8-1545109712460098">8</xref>
</sup> Nonetheless, while improving AIDS-related prognosis, current ART results frequently in metabolic abnormalities, such as dyslipidemia and glucose intolerance, which increase the risk of coronary artery disease (CAD). Nowadays, HIV-infected patients most likely die from common chronic conditions, such as cardiovascular disease, than from opportunistic infections.<sup>
<xref ref-type="bibr" rid="bibr9-1545109712460098">9</xref><xref ref-type="bibr" rid="bibr10-1545109712460098"/><xref ref-type="bibr" rid="bibr11-1545109712460098"/><xref ref-type="bibr" rid="bibr12-1545109712460098"/>–<xref ref-type="bibr" rid="bibr13-1545109712460098">13</xref>
</sup>
</p>
<p>In general populations, the exercise treadmill test (ETT) has been extensively employed for the stratification of cardiovascular risk and as a guide for the institution of therapies and exercise programs. The ETT provides plenty of data that are consistent predictors of outcome; one of them, exercise capacity, is strongly related to cardiovascular prognosis, in individuals infected with HIV or not.<sup>
<xref ref-type="bibr" rid="bibr14-1545109712460098">14</xref>
</sup>
<sup>–<xref ref-type="bibr" rid="bibr16-1545109712460098">16</xref>
</sup> Chronotropic incompetence (CI) and abnormal postexercise heart rate recovery (HRR) have also been defined as the markers of cardiovascular risk, either for CAD or all-cause death.<sup>
<xref ref-type="bibr" rid="bibr17-1545109712460098">17</xref><xref ref-type="bibr" rid="bibr18-1545109712460098"/><xref ref-type="bibr" rid="bibr19-1545109712460098"/>–<xref ref-type="bibr" rid="bibr20-1545109712460098">20</xref>
</sup> In a group of HIV-infected patients on ART, Cade et al have also observed impaired postexercise HRR and have suggested a link with autonomic neuropathy,<sup>
<xref ref-type="bibr" rid="bibr21-1545109712460098">21</xref>
</sup> which has been frequently found in this population, especially in the more advanced cases.<sup>
<xref ref-type="bibr" rid="bibr22-1545109712460098">22</xref>
</sup> Nonetheless, currently there are still no specific recommendations for physical evaluation of the HIV-infected patients. Therefore, we aimed to study the ETT as a tool to assess the cardiovascular responses to exercise (exercise capacity, development of CI, or abnormal HRR) and, accordingly, evaluate cardiovascular risk of HIV-infected individuals on ART.</p>
</sec>
<sec id="section2-1545109712460098" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>HIV-infected individuals aged ≥18 years, attending public, regional HIV clinics were evaluated at the National Institute of Cardiology. Inclusion criteria were the ability to walk on a treadmill, current absence of active opportunistic infections or CD4 count &lt;200 cells/mm<sup>3</sup>, absence of symptoms suggestive of CAD (typical chest pain or anginal equivalent, evaluated using a questionnaire),<sup>
<xref ref-type="bibr" rid="bibr23-1545109712460098">23</xref>
</sup> a history of cardiovascular disease (considered as history of angina, myocardial infarction, coronary angioplasty, or coronary artery bypass surgery), or chronic pulmonary disease. Exclusion criteria were third-degree left bundle branch block, baseline systolic blood pressure (BP) ≥180 mm Hg or diastolic BP ≥110 mm Hg at the time of the ETT. Written informed consent was obtained from all participants, and the study was approved by the local ethics committee.</p>
<p>Demographic, clinical, and anthropometric data were collected. All patients had fasting venous blood drawn for measures of glycemia and serum lipids. CD4 count and viral load (considered as the most recent in the previous 90 days) were extracted from medical records of the referring HIV clinics. Body mass index (BMI) was considered normal if ≥18.5 and &lt;25 kg/m<sup>2</sup>. Waist circumference was considered normal when ≤102 cm for men and ≤88 cm for women. Lipodystrophy at the face, the limbs, and the abdomen was defined by patients’ self-report or by an investigator’s observation of morphological changes in body composition (peripheral lipoatrophy or central fat accumulation). Baseline hypertension was defined as systolic BP ≥140 mm Hg, diastolic BP ≥90 mm Hg, or use of antihypertensive medication. Diabetes was defined according to the American Diabetes Association criteria or by the use of hypoglycemic agents.<sup>
<xref ref-type="bibr" rid="bibr24-1545109712460098">24</xref>
</sup> Total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides were considered abnormal using cutoff limits defined by the National Cholesterol Education Program for individuals with ≥2 risk factors for CAD.<sup>
<xref ref-type="bibr" rid="bibr25-1545109712460098">25</xref>
</sup>
</p>
<sec id="section3-1545109712460098">
<title>Exercise Test Protocol</title>
<p>All patients underwent a Bruce treadmill protocol.<sup>
<xref ref-type="bibr" rid="bibr26-1545109712460098">26</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr27-1545109712460098">27</xref>
</sup> Patients using β-blockers withdrew the drug 48 hours before the ETT. The test might be stopped due to exhaustion, exercise-limiting leg discomfort or chest pain, systolic BP ≥240 mm Hg, or diastolic BP ≥140 (in previously hypertensive patients, or ≥120 mm Hg in individuals without baseline hypertension), or if life-threatening arrhythmias occurred.</p>
<p>The electrocardiographic response to exercise was considered ischemic if patients developed ≥1.5 mm ascending ST segment depression or ≥1 mm horizontal ST segment depression. Blood pressure response to exercise was considered abnormal either when systolic BP decreased ≥10 mm Hg or when systolic BP reached ≥220 mm Hg. Chronotropic incompetence was defined as the inability to reach 85% of the maximal predicted heart rate, according to age and gender.<sup>
<xref ref-type="bibr" rid="bibr17-1545109712460098">17</xref>
</sup> Abnormal HRR after exercise was defined as a decrease in heart rate of &lt;12 bpm in the first minute of recovery, compared to heart rate at peak exercise.<sup>
<xref ref-type="bibr" rid="bibr19-1545109712460098">19</xref>
</sup> Recovery from exercise was performed at 2.5 km/h with 0% incline. Estimated peak oxygen consumption (V<sc>o</sc>
<sub>2</sub> peak, mL/kg per min) was automatically calculated using the Foster equation<sup>
<xref ref-type="bibr" rid="bibr28-1545109712460098">28</xref>
</sup> in Ergo-PC software (Micromed, Brazil). Functional capacity was expressed in metabolic equivalents (METs; 1 MET = 3.5 mL O<sub>2</sub>/kg per min). Categories of poor (&lt;5 MET) or good (&gt;8 MET) functional capacity were defined according to the previous studies.<sup>
<xref ref-type="bibr" rid="bibr15-1545109712460098">15</xref>
</sup>
</p>
</sec>
<sec id="section4-1545109712460098">
<title>Statistical Analysis</title>
<p>Categorical variables were expressed as number and percentage, and compared with chi-square or Fisher exact test. Continuous variables were expressed as mean ± standard deviation or median and interquartile interval, and compared with Student <italic>t</italic> test or Mann-Whitney test. Correlations were tested using Pearson or Spearman statistics, for variables with normal or other distributions. Analyses were 2 tailed, with a <italic>P</italic> value &lt;.05 considered statistically significant. All analyses were performed with R software, version 2.14.</p>
</sec>
</sec>
<sec id="section5-1545109712460098">
<title>Results</title>
<p>Forty-nine patients, 61.2% male, aged 46.4 ± 8.4 years (30-64 years, with only 2 patients &gt;60 years) were studied. <xref ref-type="table" rid="table1-1545109712460098">Table 1</xref> depicts demographic and clinical characteristics of the study population. Risk factors for CAD were common, especially dyslipidemia, and 97.9% of the patients had ≥1 risk factor for CAD. Mean BMI was 25.9 ± 4.3; 53% of the patients were overweight, 10.2% were obese, and 4% met criteria for low body weight. Triglycerides, total cholesterol, and LDL-cholesterol levels were above the limits in 10.2%, 8.2%, and 46.9% of the patients, respectively, and HDL-cholesterol was low in 61.2% of the patients. Regarding HIV infection, mean time since diagnosis was around one decade, and most patients had been treated since they were diagnosed with HIV infection. At the time of the study, all took ART (protease inhibitors in &gt;50%). Of note, 83.6% had undetectable viral load.</p>
<table-wrap id="table1-1545109712460098" position="float">
<label>Table 1.</label>
<caption>
<p>Demographic and Clinical Variables of the Overall Study Population.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-1545109712460098" xlink:href="10.1177_1545109712460098-table1.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, y</td>
<td>46.4 ± 8.4</td>
</tr>
<tr>
<td>Male</td>
<td>30 (61.2)</td>
</tr>
<tr>
<td>Duration of HIV infection, y</td>
<td>9.9 ± 5.0</td>
</tr>
<tr>
<td>Duration of antiretroviral therapy, y</td>
<td>9.1 ± 4.8</td>
</tr>
<tr>
<td>Use of protease inhibitors</td>
<td>28 (57.1)</td>
</tr>
<tr>
<td>Hypertension</td>
<td>26 (53.0)</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>6 (12.2)</td>
</tr>
<tr>
<td>Dyslipidemia</td>
<td>29 (59.1)</td>
</tr>
<tr>
<td>Smoking</td>
<td>16 (32.6)</td>
</tr>
<tr>
<td>Family history of coronary artery disease</td>
<td>28 (57.1)</td>
</tr>
<tr>
<td>Body mass index, kg/m<sup>2</sup>
</td>
<td>25.8 ± 4.3</td>
</tr>
<tr>
<td>Waist circumference, cm</td>
<td>
</td>
</tr>
<tr>
<td> Men</td>
<td>89.3 ± 9.2</td>
</tr>
<tr>
<td> Women</td>
<td>89.9 ± 9.2</td>
</tr>
<tr>
<td>Lipodistrophy</td>
<td>28 (57.1)</td>
</tr>
<tr>
<td>Baseline systolic blood pressure, mm Hg</td>
<td>124.4 ± 20.7</td>
</tr>
<tr>
<td>Baseline diastolic blood pressure, mm Hg</td>
<td>80.2 ± 9.6</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>191.5 ± 31.2</td>
</tr>
<tr>
<td>LDL-cholesterol, mg/dL</td>
<td>117.9 ± 27.9</td>
</tr>
<tr>
<td>HDL-cholesterol, mg/dL</td>
<td>38.1 ± 11.7</td>
</tr>
<tr>
<td>Triglycerides, mg/dL<sup>b</sup>
</td>
<td>182.0</td>
</tr>
<tr>
<td>Glycemia, mg/dL</td>
<td>97.9 ± 14.2</td>
</tr>
<tr>
<td>CD4 count, cells/mm<sup>3</sup>
</td>
<td>614.6 ± 354.3 </td>
</tr>
<tr>
<td>Viral load, copies/mL<sup>b</sup>
</td>
<td>536</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1545109712460098">
<p>Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.</p>
</fn>
<fn id="table-fn2-1545109712460098">
<p>
<sup>a</sup> n = 49.</p>
</fn>
<fn id="table-fn3-1545109712460098">
<p>
<sup>b</sup> Numbers are mean ± standard deviation, n (%) or median.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="table2-1545109712460098">Table 2</xref> demonstrates the results obtained from the ETT. Exercise duration was 9.7 ± 2.1 minutes and estimated V<sc>o</sc>
<sub>2</sub> peak was 31.4 ± 4.8. Most patients (89.7%) reached &gt;8 METs. None of the patients had clinical or electrocardiographic responses suggestive of myocardial ischemia, and none developed cardiac arrhythmias with the exception of isolated ventricular extrasystoles in 1 patient. Chronotropic incompetence was found in 24.9% of the patients, abnormal HRR in 10.2%, and abnormal BP response to exercise in 15.0% (none with BP decrease). It could be argued that poor effort might account for the low heart rate; however, that is most likely not the case in this study, since (1) patients exercised to exhaustion, and none of the tests were interrupted because of chest pain or any other reason and (2) mean exercise duration was 9.7 minutes, mean exercise capacity was 9.2 METS and most patients (89.7%) reached &gt;8 METS, indicating that the majority achieved good effort levels. Only 1 patient had low exercise tolerance and reached ≤5 METS, and in this case the low effort level might indeed account for low peak heart rate. Nonetheless, we believe that it would not significantly affect overall results.</p>
<table-wrap id="table2-1545109712460098" position="float">
<label>Table 2.</label>
<caption>
<p>Data from Exercise Treadmill Test.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table2-1545109712460098" xlink:href="10.1177_1545109712460098-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Mean ± SD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baseline heart rate, bpm</td>
<td>75.1 ± 16.1</td>
</tr>
<tr>
<td>Peak heart rate, bpm</td>
<td>159.6 ± 18.3</td>
</tr>
<tr>
<td>Maximal systolic blood pressure, mm Hg</td>
<td>188.5 ± 28.6</td>
</tr>
<tr>
<td>Maximal diastolic blood pressure, mm Hg</td>
<td>83.4 ± 14.3</td>
</tr>
<tr>
<td>MET</td>
<td>9.2 ± 1.6</td>
</tr>
<tr>
<td>Estimated V<sc>o</sc>
<sub>2</sub> peak, mL/kg per min</td>
<td>31.4 ± 4.8</td>
</tr>
<tr>
<td>Duration, min</td>
<td>9.7 ± 2.1 </td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1545109712460098">
<p>Abbreviations: MET, metabolic equivalent; SD, standard deviation; V<sc>o</sc>
<sub>2</sub> peak, oxygen consumption at peak exercise.</p>
</fn>
<fn id="table-fn5-1545109712460098">
<p>
<sup>a</sup> n = 49 patients; 30 men, 19 women.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>There was an inverse correlation between age and estimated V<sc>o</sc>
<sub>2</sub> peak (rho = −0.34, <italic>P</italic> &lt; .05), as well as BMI and V<sc>o</sc>
<sub>2</sub> peak (rho = −0.46, <italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig1-1545109712460098">Figures 1</xref> and <xref ref-type="fig" rid="fig2-1545109712460098">2</xref>). Estimated V<sc>o</sc>
<sub>2</sub> peak was also significantly lower in women (29.1 [29.0-31.3]) than in men (32.8 [30.5-37.2]; <italic>P</italic> &lt; .05). No other variables, including those related to the status of HIV infection, such as CD4 count or viral load, had any significant association with V<sc>o</sc>
<sub>2</sub> peak.</p>
<fig id="fig1-1545109712460098" position="float">
<label>Figure 1.</label>
<caption>
<p>Correlation between age and oxygen consumption (V<sc>o</sc>
<sub>2</sub>) peak.</p>
</caption>
<graphic xlink:href="10.1177_1545109712460098-fig1.tif"/>
</fig>
<fig id="fig2-1545109712460098" position="float">
<label>Figure 2.</label>
<caption>
<p>Correlation between body mass index (BMI) and oxygen consumption (V<sc>o</sc>
<sub>2</sub>) peak.</p>
</caption>
<graphic xlink:href="10.1177_1545109712460098-fig2.tif"/>
</fig>
<p>
<xref ref-type="table" rid="table3-1545109712460098">Tables 3</xref> and <xref ref-type="table" rid="table4-1545109712460098">4</xref> display univariate comparisons of variables in patients with or without CI or abnormal HRR. There were no significant associations between clinical variables and abnormal HR responses to exercise or during recovery from it.</p>
<table-wrap id="table3-1545109712460098" position="float">
<label>Table 3.</label>
<caption>
<p>Comparisons between Patients With or Without Chronotropic Incompetence (CI).</p>
</caption>
<graphic alternate-form-of="table3-1545109712460098" xlink:href="10.1177_1545109712460098-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Without CI, n = 32</th>
<th>With CI, n = 17</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, y</td>
<td>45.3 ± 8.9</td>
<td>48.5 ± 7.5</td>
</tr>
<tr>
<td>Male</td>
<td>20 (62.5)</td>
<td>12 (70.6)</td>
</tr>
<tr>
<td>Hypertension</td>
<td>17 (53.1)</td>
<td>9 (52.9)</td>
</tr>
<tr>
<td>Diabetes</td>
<td>4 (12.5)</td>
<td>2 (11.8)</td>
</tr>
<tr>
<td>Smoking</td>
<td>12 (37.5)</td>
<td>4 (23.5)</td>
</tr>
<tr>
<td>Dyslipidemia</td>
<td>16 (50.0)</td>
<td>13 (76.5)</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>190.1 ± 34.8</td>
<td>194.1 ± 26.8</td>
</tr>
<tr>
<td>Body mass index<sup>a</sup>, kg/m<sup>2</sup>
</td>
<td align="center">26.0</td>
<td align="center">26.5 </td>
</tr>
<tr>
<td>Viral load, copies/mL<sup>a</sup>
</td>
<td align="center">588</td>
<td align="center">485</td>
</tr>
<tr>
<td>HIV infection duration, years</td>
<td>9.7 ± 5.6 </td>
<td>10,2 ± 3,8</td>
</tr>
<tr>
<td>Use of protease inhibitors</td>
<td>16 (50.0)</td>
<td>12 (70.6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1545109712460098">
<p>
<sup>a</sup> Numbers are mean ± standard deviation, n (%) or median.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table4-1545109712460098" position="float">
<label>Table 4.</label>
<caption>
<p>Comparisons between Patients With Normal or Abnormal Heart Rate Recovery (HRR) after Exercise.</p>
</caption>
<graphic alternate-form-of="table4-1545109712460098" xlink:href="10.1177_1545109712460098-table4.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Normal HRR, n = 44</th>
<th>Abnormal HRR, n = 5</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, y</td>
<td>46.2 ± 8.2</td>
<td>48.2 ± 11.1</td>
</tr>
<tr>
<td>Male</td>
<td>26 (59.1)</td>
<td>4 (80.0)</td>
</tr>
<tr>
<td>Hypertension</td>
<td>24 (54.5)</td>
<td>2 (40.0)</td>
</tr>
<tr>
<td>Diabetes</td>
<td>5 (11.4)</td>
<td>1 (20.0)</td>
</tr>
<tr>
<td>Smoking</td>
<td>14 (31.2)</td>
<td>2 (40.0)</td>
</tr>
<tr>
<td>Dyslipidemia</td>
<td>26 (59.1)</td>
<td>3 (60.0)</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>190.6 ± 32.8</td>
<td>199.4 ± 15.5</td>
</tr>
<tr>
<td>Body mass index<sup>a</sup>, kg/m<sup>2</sup>
</td>
<td align="center">26.0</td>
<td align="center">26.7 </td>
</tr>
<tr>
<td>Viral load, copies/mL<sup>a</sup>
</td>
<td align="center">585</td>
<td align="center">468</td>
</tr>
<tr>
<td>HIV infection duration, years</td>
<td>9.8 ± 5.3</td>
<td>10.8 ± 5.0</td>
</tr>
<tr>
<td>Use of protease inhibitors</td>
<td>24 (54.5)</td>
<td>4 (80.0)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-1545109712460098">
<p>
<sup>a</sup> Numbers are mean ± standard deviation, n (%) or median.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-1545109712460098">
<title>Discussion</title>
<p>With effective ART, HIV-infected patients are surviving longer; in parallel, susceptibility to cardiovascular disease has also increased.<sup>
<xref ref-type="bibr" rid="bibr29-1545109712460098">29</xref>
</sup>
<sup>–<xref ref-type="bibr" rid="bibr32-1545109712460098">32</xref>
</sup> In this sense, the evaluation of cardiovascular risk in these patients is relevant to plan interventions aiming at improving cardiovascular prognosis. Whereas there are many studies using the ETT for cardiovascular risk assessment either in healthy populations or in patients with known cardiovascular disease, few have focused on the (increasingly large) population of HIV-infected patients.<sup>
<xref ref-type="bibr" rid="bibr33-1545109712460098">33</xref>
</sup>
<sup>–<xref ref-type="bibr" rid="bibr36-1545109712460098">36</xref>
</sup> In this investigation, we studied the associations between patients’ characteristics and abnormal exercise capacity (evaluated using estimated V<sc>o</sc>
<sub>2</sub>) as well as other risk markers (CI and abnormal HRR) obtained from the ETT. These markers may be linked, in HIV-infected patients, to CAD or autonomic dysfunction,<sup>
<xref ref-type="bibr" rid="bibr34-1545109712460098">34</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr37-1545109712460098">37</xref>,<xref ref-type="bibr" rid="bibr38-1545109712460098">38</xref>
</sup> in line with the increased risk of CAD in this patient population<sup>
<xref ref-type="bibr" rid="bibr29-1545109712460098">29</xref>
</sup>
<sup>–<xref ref-type="bibr" rid="bibr32-1545109712460098">32</xref>
</sup> as well as with several reports of autonomic neuropathy in these patients.<sup>
<xref ref-type="bibr" rid="bibr22-1545109712460098">22</xref>,<xref ref-type="bibr" rid="bibr37-1545109712460098">37</xref>
<xref ref-type="bibr" rid="bibr38-1545109712460098"/>
<xref ref-type="bibr" rid="bibr39-1545109712460098"/>–<xref ref-type="bibr" rid="bibr40-1545109712460098">40</xref>
</sup> Abnormal recovery of heart rate after exercise, a sign of reduced vagal tone, matches the findings of ineffective vagal response to cold-face testa and abnormal sympathovagal balance, described by Correia et al.<sup>
<xref ref-type="bibr" rid="bibr40-1545109712460098">40</xref>
</sup> In general, autonomic dysfunction has been most often considered to be caused by the virus itself, what is supported by prior evidence showing the lack of autonomic neuropathy in AIDS patients receiving ART,<sup>
<xref ref-type="bibr" rid="bibr22-1545109712460098">22</xref>,<xref ref-type="bibr" rid="bibr40-1545109712460098">40</xref>,<xref ref-type="bibr" rid="bibr41-1545109712460098">41</xref>
</sup> while CAD has multiple possible causes, including the direct effect of HIV on the vascular endothelium and indirect effects of ART (related to dyslipidemia associated with protease inhibitors).<sup>
<xref ref-type="bibr" rid="bibr11-1545109712460098">11</xref>
<xref ref-type="bibr" rid="bibr12-1545109712460098"/>–<xref ref-type="bibr" rid="bibr13-1545109712460098">13</xref>,<xref ref-type="bibr" rid="bibr29-1545109712460098">29</xref>
<xref ref-type="bibr" rid="bibr30-1545109712460098"/>
<xref ref-type="bibr" rid="bibr31-1545109712460098"/>–<xref ref-type="bibr" rid="bibr32-1545109712460098">32</xref>
</sup>
</p>
<p>This was a relatively young patient group, compared with patients with cardiovascular disease. Therefore, despite the long duration of infection (around 10 years), as well as the high prevalence of risk factors for CAD, the degree of functional impairment in these patients was low. One must have in mind, though, that in the current study, patients had been treated for most of the time since diagnosis of infection, and that at the time data were collected, all took ART, the CD4 count was above AIDS-defining limits, and viral load was undetectable in the majority, what may not reflect the overall HIV-infected population. Indeed, patients with low CD4 were excluded even in the absence of opportunistic infections because of the known association between CD4 count and physical function<sup>
<xref ref-type="bibr" rid="bibr2-1545109712460098">2</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr5-1545109712460098">5</xref>
</sup> which could introduce some confusion when studying cardiorespiratory fitness and its relationship with cardiac disease.</p>
<p>In this study, respiratory gas analysis was not available and, therefore, V<sc>o</sc>
<sub>2</sub> was estimated. It is worth noting, though, that while directly measured V<sc>o</sc>
<sub>2</sub> is more precise, it is less often available, since it requires additional expertise and costs related to the required equipment. On the contrary, V<sc>o</sc>
<sub>2</sub> estimates based on validated equations are routinely obtained in most clinical facilities and have demonstrated an important role as a functional capacity indicator,<sup>
<xref ref-type="bibr" rid="bibr42-1545109712460098">42</xref>
</sup> therefore, moving our results closer to “real-world” settings.</p>
<p>In this study, increasing age and weight were associated with poorer cardiorespiratory fitness, as previously described both in general and in HIV-infected populations.<sup>
<xref ref-type="bibr" rid="bibr6-1545109712460098">6</xref>,<xref ref-type="bibr" rid="bibr7-1545109712460098">7</xref>,<xref ref-type="bibr" rid="bibr43-1545109712460098">43</xref>,<xref ref-type="bibr" rid="bibr44-1545109712460098">44</xref>
</sup> Women had also lower estimated V<sc>o</sc>
<sub>2</sub> peak, again following common general patterns.<sup>
<xref ref-type="bibr" rid="bibr45-1545109712460098">45</xref>
</sup> These results indicate a subgroup of patients with HIV receiving ART—the older, overweight/obese HIV-infected patients—who might deserve periodic cardiovascular screening with ETT. Indeed, in a recent study of patients with HIV/AIDS, obesity was associated with angina pectoris, even after adjustment for age.<sup>
<xref ref-type="bibr" rid="bibr46-1545109712460098">46</xref>
</sup> Of note, CD4 count and viral load were not correlated to estimated V<sc>o</sc>
<sub>2</sub> peak, possibly due to the fact that all patients had relatively high CD4 count and most had undetectable viral load, which might—in a small patient sample—have limited the detection of differences between variables.</p>
<p>Neither clinical nor electrocardiographic ischemic responses were found in any of the study patients. This contrasts with the results of Duong et al who found 11% of ischemic electrocardiographic responses in the ETT of HIV-infected patients.<sup>
<xref ref-type="bibr" rid="bibr34-1545109712460098">34</xref>
</sup> However, their population had a higher proportion of men, and, importantly, some of the patients met AIDS-defining criteria and were therefore in a more advanced stage of infection than our study population, which may account for the difference. Nonetheless, other markers of cardiovascular risk were found; one-fourth of the patients had CI, and 10.2% had abnormal HRR, which may allocate these patients to a higher risk category.</p>
</sec>
<sec id="section7-1545109712460098">
<title>Limitations</title>
<p>This was a small, single-center study of highly select patients, which limits the generalizability of the conclusions. Nonetheless, we believe that the homogeneity of the studied population may be helpful for the understanding of the pathophysiology of disease in that specific subgroup and may also allow more specific conclusions, which might not be possible if “mixed” patients were studied.</p>
</sec>
<sec id="section8-1545109712460098">
<title>Conclusions</title>
<p>The study started under the premise that there might be variables associated with poor functional capacity or with other abnormal responses to exercise which might be potentially modifiable, thus possibly having a favorable effect on prognosis. According to our results, overweight and obesity should be especially targeted, due to the negative correlation between BMI and V<sc>o</sc>
<sub>2</sub> peak. Engelson et al<sup>
<xref ref-type="bibr" rid="bibr47-1545109712460098">47</xref>
</sup> have studied the effects of diet and exercise programs for weight loss on obese HIV-infected women and observed moderate weight loss, although no significant change in metabolic parameters, such as glycemia or serum lipids, occurred; the investigators suggested that additional interventions might be necessary to reduce the risk of cardiovascular disease. On the other hand, other studies have found favorable effects of exercise on metabolic indices and autonomic function,<sup>
<xref ref-type="bibr" rid="bibr48-1545109712460098">48</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr49-1545109712460098">49</xref>
</sup> as well as a decrease in BMI and an increase in oxygen consumption in HIV-infected patients.<sup>
<xref ref-type="bibr" rid="bibr50-1545109712460098">50</xref>
</sup> Several studies have reported efforts toward early recognition of reduction in exercise capacity in the HIV-infected group, as well as initiatives regarding exercise training in the HIV-infected population.<sup>
<xref ref-type="bibr" rid="bibr51-1545109712460098">51</xref>
</sup>
<sup>,<xref ref-type="bibr" rid="bibr52-1545109712460098">52</xref>
</sup> Further research in this area may help find ways to prevent decline in functional capacity in these individuals, which may in turn result in improved cardiovascular prognosis.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Mr Marcelo Barros and Mrs Ana Beatriz Lima for their contribution in data collection, and Bernardo Tura, MD, PhD, for statistical assistance.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-1545109712460098">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1545109712460098">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1545109712460098">
<label>1</label>
<citation citation-type="web">
<collab collab-type="author">The Joint United Nations Programme on HIV/AIDS</collab>. <article-title>AIDS epidemic update</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en[1].pdf">http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en[1].pdf</ext-link>. <comment>Accessed November 2011</comment>.</citation>
</ref>
<ref id="bibr2-1545109712460098">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanton</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>RD</given-names>
</name>
<etal/>
</person-group> <article-title>Functional status of persons with HIV infection in an ambulatory setting</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>1994</year>;<volume>7</volume>(<issue>10</issue>):<fpage>1050</fpage>–<lpage>1056</lpage>.</citation>
</ref>
<ref id="bibr3-1545109712460098">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grinspoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1999</year>;<volume>84</volume>(<issue>1</issue>):<fpage>201</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr4-1545109712460098">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crystal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fleishman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hays</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bozzette</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>Physical and role functioning among persons with HIV: results from a nationally representative survey</article-title>. <source>Med Care</source>. <year>2000</year>;<volume>38</volume>(<issue>12</issue>):<fpage>1210</fpage>–<lpage>1223</lpage>.</citation>
</ref>
<ref id="bibr5-1545109712460098">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rusch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schilder</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Braitstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hoqq</surname>
<given-names>RS</given-names>
</name>
</person-group>. <article-title>Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia</article-title>. <source>Health Qual Life Outcomes</source>. <year>2004</year>;<volume>2</volume>:<fpage>46</fpage>.</citation>
</ref>
<ref id="bibr6-1545109712460098">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Cleary</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Clinical predictors of decline in physical functioning in persons with AIDS: results of a longitudinal study</article-title>. <source>J Acquir Immune Defic Syndr Hum Retrovirol</source>. <year>1997</year>;<volume>16</volume>(<issue>5</issue>):<fpage>343</fpage>–<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr7-1545109712460098">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oursler</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Sorkin</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Katzel</surname>
<given-names>LI</given-names>
</name>
</person-group>. <article-title>Reduced aerobic capacity and physical functioning in older HIV-infected men</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2006</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1113</fpage>–<lpage>1121</lpage>.</citation>
</ref>
<ref id="bibr8-1545109712460098">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oursler</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Goulet</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Leaf</surname>
<given-names>DA</given-names>
</name>
<etal/>
</person-group> <article-title>Association of comorbidity with physical disability in older HIV-infected adults</article-title>. <source>AIDS Patient Care STDS</source>. <year>2006</year>;<volume>20</volume>(<issue>11</issue>):<fpage>782</fpage>–<lpage>791</lpage>.</citation>
</ref>
<ref id="bibr9-1545109712460098">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gange</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>RD</given-names>
</name>
</person-group>. <article-title>Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2007</year>;<volume>44</volume>(<issue>2</issue>):<fpage>179</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr10-1545109712460098">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palella</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Moorman</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group> <article-title>Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2006</year>;<volume>43</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr11-1545109712460098">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Melroe</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huebsch</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Severe premature coronary artery disease with protease inhibitors</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>351</volume>(<issue>9112</issue>):<fpage>1328</fpage>.</citation>
</ref>
<ref id="bibr12-1545109712460098">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Currier</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dezii</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kawabata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Burtcell</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Coronary heart diseases in HIV-infected individuals</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2003</year>;<volume>33</volume>(<issue>4</issue>):<fpage>506</fpage>–<lpage>512</lpage>.</citation>
</ref>
<ref id="bibr13-1545109712460098">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Triant</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hadigan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grinspoon</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2007</year>;<volume>92</volume>(<issue>7</issue>):<fpage>2506</fpage>–<lpage>2512</lpage>.</citation>
</ref>
<ref id="bibr14-1545109712460098">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Froelicher</surname>
<given-names>VF</given-names>
</name>
</person-group>. <article-title>Clinical and exercise test markers of prognosis in patients with stable coronary artery disease</article-title>. <source>Curr Probl Cardiol</source>. <year>1994</year>;<volume>19</volume>(<issue>9</issue>):<fpage>533</fpage>–<lpage>587</lpage>.</citation>
</ref>
<ref id="bibr15-1545109712460098">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Froelicher</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Partington</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atwood</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Exercise capacity and mortality among men referred for exercise testing</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>346</volume>(<issue>11</issue>):<fpage>793</fpage>–<lpage>801</lpage>.</citation>
</ref>
<ref id="bibr16-1545109712460098">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talbot</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Morrell</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Metter</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Fleg</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Comparison of cardiorespiratory fitness versus leisure time physical activity as predictors of coronary events in men aged &lt;or = 65 years and &gt;65 years</article-title>. <source>Am J Cardiol</source>. <year>2002</year>;<volume>89</volume>(<issue>10</issue>):<fpage>1187</fpage>–<lpage>1192</lpage>.</citation>
</ref>
<ref id="bibr17-1545109712460098">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauer</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Okin</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Pashkow</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Snader</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Marwick</surname>
<given-names>TH</given-names>
</name>
</person-group>. <article-title>Impaired chronotropic response to exercise stress testing as a predictor of mortality</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>281</volume>(<issue>6</issue>):<fpage>524</fpage>–<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr18-1545109712460098">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elhendy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mahoney</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Khanderia</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pelikka</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia</article-title>. <source>J Am Coll Cardiol</source>. <year>2003</year>;<volume>42</volume>(<issue>5</issue>):<fpage>823</fpage>–<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr19-1545109712460098">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Blackstone</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Pashkow</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Snader</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lauer</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Heart rate recovery immediately after exercise as a predictor of mortality</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>341</volume>(<issue>18</issue>):<fpage>1351</fpage>–<lpage>1357</lpage>.</citation>
</ref>
<ref id="bibr20-1545109712460098">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vivekananthan</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Blackstone</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Pothier</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lauer</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease</article-title>. <source>J Am Coll Cardiol</source>. <year>2003</year>;<volume>42</volume>(<issue>5</issue>):<fpage>831</fpage>–<lpage>838</lpage>.</citation>
</ref>
<ref id="bibr21-1545109712460098">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cade</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Reeds</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Lassa-Claxton</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?</article-title> <source>HIV Med</source>. <year>2008</year>;<volume>9</volume>(<issue>2</issue>):<fpage>96</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr22-1545109712460098">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruttimann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hilti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spinas</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Dubach</surname>
<given-names>UC</given-names>
</name>
</person-group>. <article-title>High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease</article-title>. <source>Arch Intern Med</source>. <year>1991</year>;<volume>151</volume>:<fpage>2441</fpage>–<lpage>2443</lpage>.</citation>
</ref>
<ref id="bibr23-1545109712460098">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McCatney</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>DD</given-names>
</name>
</person-group>. <article-title>Self-administration of a questionnaire on chest pain and intermittent claudication</article-title>. <source>Br J Prev Soc Med</source>. <year>1977</year>;<volume>31</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr24-1545109712460098">
<label>24</label>
<citation citation-type="journal">
<collab collab-type="author">American Diabetes Association</collab>. <article-title>Diagnosis and classification of diabetes mellitus</article-title>. <source>Diabetes Care</source>. <year>2010</year>;<volume>33</volume>(<issue>suppl 1</issue>):<fpage>S62</fpage>.</citation>
</ref>
<ref id="bibr25-1545109712460098">
<label>25</label>
<citation citation-type="journal">
<collab collab-type="author">National Cholesterol Education Program (NCEP)</collab> <article-title>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>25</issue>):<fpage>3143</fpage>–<lpage>3421</lpage>.</citation>
</ref>
<ref id="bibr26-1545109712460098">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruce</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Lovejoy</surname>
<given-names>FW</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Yu</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Mc Dowell</surname>
<given-names>ME.</given-names>
</name>
</person-group> <article-title>Observations of cardiorespiratory performance in normal subjects under unusual stress during exercise</article-title>. <source>AMA Arch Ind Hyg Occup Med</source>. <year>1952</year>;<volume>6</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr27-1545109712460098">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruce</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Kusumi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hosmer</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease</article-title>. <source>Am Heart J</source>. <year>1973</year>;<volume>85</volume>(<issue>4</issue>):<fpage>546</fpage>–<lpage>562</lpage>.</citation>
</ref>
<ref id="bibr28-1545109712460098">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crowe</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Daines</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Predicting functional capacity during treadmill testing independent of exercise protocol</article-title>. <source>Med Sci Sports Exerc</source>. <year>1996</year>;<volume>28</volume>(<issue>6</issue>):<fpage>752</fpage>–<lpage>756</lpage>.</citation>
</ref>
<ref id="bibr29-1545109712460098">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vittecoq</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Escaut</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Monsuez</surname>
<given-names>JJ</given-names>
</name>
</person-group>. <article-title>Vascular complications associated with use of HIV protease inhibitors</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>351</volume>(<issue>9120</issue>):<fpage>1959</fpage>.</citation>
</ref>
<ref id="bibr30-1545109712460098">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamin</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Grinspoon</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Cardiovascular disease in HIV-positive patients</article-title>. <source>AIDS</source>. <year>2005</year>;<volume>19</volume>(<issue>7</issue>):<fpage>641</fpage>–<lpage>652</lpage>.</citation>
</ref>
<ref id="bibr31-1545109712460098">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fris-Møller</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sabin</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction</article-title>. <source>N Engl J Med</source>. <year>2003</year>;<volume>349</volume>(<issue>21</issue>):<fpage>1993</fpage>–<lpage>2003</lpage>.</citation>
</ref>
<ref id="bibr32-1545109712460098">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Currier</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lundgran</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy</article-title>. <source>Circulation</source>. <year>2008</year>;<volume>118</volume>(<issue>2</issue>):<fpage>e29</fpage>–<lpage>e35</lpage>.</citation>
</ref>
<ref id="bibr33-1545109712460098">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keyser</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Peralta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cade</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anixt</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Functional aerobic impairment in adolescents seropostive for HIV: a quasiexperimental design</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2000</year>;<volume>81</volume>(<issue>11</issue>):<fpage>1479</fpage>–<lpage>1484</lpage>.</citation>
</ref>
<ref id="bibr34-1545109712460098">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cottin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Piroth</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapy</article-title>. <source>Clin Infect Dis</source>. <year>2002</year>;<volume>34</volume>(<issue>4</issue>):<fpage>523</fpage>–<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr35-1545109712460098">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>High</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Quagliarello</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measure</article-title>. <source>Clin Infect Dis</source>. <year>2005</year>;<volume>40</volume>(<issue>1</issue>):<fpage>114</fpage>–<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr36-1545109712460098">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oursler</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Katzel</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Russ</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Sorkin</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Prediction of cardiorespiratory fitness in older men Infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance</article-title>. <source>J Am Geriatr Soc</source>. <year>2009</year>;<volume>57</volume>(<issue>11</issue>):<fpage>2055</fpage>–<lpage>2061</lpage>.</citation>
</ref>
<ref id="bibr37-1545109712460098">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin-Greenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taneja-Upal</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Dysautonomia and infection with the human immunodeficiency virus</article-title>. <source>Ann Intern Med</source>. <year>1987</year>;<volume>106</volume>(<issue>1</issue>):<fpage>167</fpage>.</citation>
</ref>
<ref id="bibr38-1545109712460098">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Broadbridge</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Autonomic function and HIV</article-title>. <source>Neurology</source>. <year>1990</year>;<volume>40</volume>(<issue>4</issue>):<fpage>575</fpage>–<lpage>580</lpage>.</citation>
</ref>
<ref id="bibr39-1545109712460098">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogstad</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tesfaladet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ahmed-Jushuf</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Cardiovascular autonomic neuropathy in HIV infected patients</article-title>. <source>Sex Transm Inf</source>. <year>1999</year>;<volume>75</volume>(<issue>4</issue>):<fpage>264</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr40-1545109712460098">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rodrigues de Resende</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>RJ</given-names>
</name>
<etal/>
</person-group> <article-title>Power spectral analysis of heart rate variability in HIV-infected and AIDS patients</article-title>. <source>Pacing Clin Electrophysiol</source>. <year>2006</year>;<volume>29</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr41-1545109712460098">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craddock</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pasvol</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bull</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Protheroe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hopkin</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Cardiorespiratory arrest and autonomic neuropathy in AIDS</article-title>. <source>Lancet</source>. <year>1987</year>;<volume>2</volume>(<issue>8549</issue>):<fpage>16</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr42-1545109712460098">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snader</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Marwick</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Pashkow</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Lauer</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single photon emission computed tomography: report of 3,400 patients from a single center</article-title>. <source>J Am Coll Cardiol</source>. <year>1997</year>;<volume>30</volume>(<issue>3</issue>):<fpage>641</fpage>–<lpage>648</lpage>.</citation>
</ref>
<ref id="bibr43-1545109712460098">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janssen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Katzmarzyk</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Waist circumference and not body mass index explains obesity-related health risk</article-title>. <source>Am J Clin Nutr</source>. <year>2004</year>;<volume>79</volume>:<fpage>379</fpage>–<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr44-1545109712460098">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sui</surname>
<given-names>X</given-names>
</name>
<name>
<surname>LaMonte</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Laditka</surname>
<given-names>JN</given-names>
</name>
<etal/>
</person-group> <article-title>Cardiorespiratory fitness and adiposity as mortality predictors in older adults</article-title>. <source>JAMA</source>. <year>2007</year>;<volume>298</volume>(<issue>21</issue>):<fpage>2507</fpage>–<lpage>2516</lpage>.</citation>
</ref>
<ref id="bibr45-1545109712460098">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>LJ</given-names>
</name>
<etal/>
</person-group> <article-title>The prognostic value of a nomogram for exercise capacity in women</article-title>. <source>N Engl J Med</source>. <year>2005</year>;<volume>353</volume>(<issue>5</issue>):<fpage>468</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr46-1545109712460098">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zirpoli</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lacerda</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>de Albuquerque</surname>
<given-names>VM</given-names>
</name>
<etal/>
</person-group> <article-title>Angina pectoris in patients with HIV/AIDS: prevalence and risk factors</article-title>. <source>Braz J Infect Dis</source>. <year>2012</year>;<volume>16</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr47-1545109712460098">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engelson</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Agin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kenya</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women</article-title>. <source>Metabolism</source>. <year>2006</year>;<volume>55</volume>(<issue>10</issue>):<fpage>1327</fpage>–<lpage>1336</lpage>.</citation>
</ref>
<ref id="bibr48-1545109712460098">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Multimura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Crowther</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Cade</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Yarasheski</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Exercise training reduced central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: a randomized controlled trial</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2008</year>;<volume>24</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr49-1545109712460098">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spierer</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>DeMeersman</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Kleinfield</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Exercise training improves cardiovascular and autonomic profiles in HIV</article-title>. <source>Clin Auton Res</source>. <year>2007</year>;<volume>17</volume>(<issue>6</issue>):<fpage>341</fpage>–<lpage>348</lpage>.</citation>
</ref>
<ref id="bibr50-1545109712460098">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogalha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sampaio</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>A randomized, clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology and metabolic parameters of patients with AIDS in Salvador, Brazil</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2011</year>;<volume>57</volume>(<issue>suppl 3</issue>):<fpage>S179</fpage>–<lpage>S185</lpage>.</citation>
</ref>
<ref id="bibr51-1545109712460098">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinn</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hadigan</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>TT</given-names>
</name>
<etal/>
</person-group> <article-title>Prevention strategies for cardiovascular disease in HIV-infected patients</article-title>. <source>Circulation</source>. <year>2008</year>;<volume>118</volume>(<issue>2</issue>):<fpage>e54</fpage>–<lpage>e60</lpage>.</citation>
</ref>
<ref id="bibr52-1545109712460098">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>ÓBrien</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tynan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Glazier</surname>
<given-names>R.</given-names>
</name>
</person-group> <article-title>Aerobic exercise interventions for adults living with HIV/AIDS</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2010</year>;(<volume>8</volume>):<fpage>CD001796</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>